DMPA self-administration can improve contraceptive access, continuation, and autonomy
Main Author: | Julia E Kohn |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-05-01
|
Series: | The Lancet Global Health |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214109X18300779 |
Similar Items
-
Cost-effectiveness of self-injected DMPA-SC compared with health-worker-injected DMPA-IM in Senegal
by: Mercy Mvundura, et al.
Published: (2019-01-01) -
Comparison of Two Different Injectable Contraceptive Methods: Depo-medroxy Progesterone Acetate (DMPA) and Cyclofem.
by: Firoozeh Veisi, et al.
Published: (2013-09-01) -
The Description of Lipid Profile on Injectable DMPA Contraception Acceptors in Public Health Center Banjarsengon, Jember District
by: Ririn Handayani, et al.
Published: (2021-04-01) -
The role of partners in promoting self-care for misoprostol and subcutaneous DMPA in Pakistan
by: Qudsia Uzma, et al.
Published: (2021-04-01) -
Bone mineral density and use of depot medroxyprogesterone acetate (DMPA), norethisterone enanthate (NET-EN) and combined oral contraceptives
by: Beksinska, Malgorzata Elzbieta
Published: (2010)